These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6254886)
1. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs. Donnenberg AD; Chaikof E; Aurelian L Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886 [TBL] [Abstract][Full Text] [Related]
2. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs. Donnenberg AD; Bell RB; Aurelian L Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811 [No Abstract] [Full Text] [Related]
3. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Sheridan JF; Aurelian L Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056 [TBL] [Abstract][Full Text] [Related]
4. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224 [TBL] [Abstract][Full Text] [Related]
5. Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors. Iwasaka T; Sheridan JF; Aurelian L Infect Immun; 1983 Dec; 42(3):955-64. PubMed ID: 6227561 [TBL] [Abstract][Full Text] [Related]
6. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D. Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094 [TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus. Zaia JA; Palmer EL; Feorino PM J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562 [TBL] [Abstract][Full Text] [Related]
15. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation. Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro. Sheridan JF; Beck M; Smith CC; Aurelian L J Immunol; 1987 Feb; 138(4):1234-9. PubMed ID: 3027176 [TBL] [Abstract][Full Text] [Related]
17. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease. Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519 [TBL] [Abstract][Full Text] [Related]
18. Animal studies on the efficacy of vaccination against recurrent herpes. Scriba M Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061 [TBL] [Abstract][Full Text] [Related]
19. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D. Aurelian L; Smith CC; Wachsman M; Paoletti E Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130 [TBL] [Abstract][Full Text] [Related]
20. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. Cunningham AL; Noble JR J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]